A Lung Legend
"Dr. Ramirez is passionate about lung cancer and his research," writes Kristen Gurba in a submission for the CURE® Lung Cancer Heroes® Award.
Dr. Robert Ramirez. Photo provided by Ochsner Health.
Dr. Robert Ramirez is a physician at the NOLANETS clinic at Ochsner Health. He has clinical and research interests in lung cancer, specifically non-small cell and small cell cancers, as well as neuroendocrine tumors of the lung, including diffuse, idiopathic, pulmonary, neuroendocrine, cell hyperplasia, typical and atypical carcinoids. He has given multiple presentations at national and international meetings on lung cancer and neuroendocrine tumors and has multiple peer-reviewed publications. He is a recognized thought leader in these fields. He splits his clinical and research duties between the Ochsner Lung Cancer Multidisciplinary Program and the Ochsner Kenner/LSU Multidisciplinary Neuroendocrine Clinic. He is active in clinical trial design as well as teaching fellows, residents and medical students.
Dr. Ramirez is passionate about lung cancer and his research.
FDA Approves Lazcluze Plus Rybrevant for Lung Cancer Subset
August 20th 2024The Food and Drug Administration approved frontline Lazcluze plus Rybrevant for locally advanced or metastatic non-small cell lung cancer with an EGFR exon 19 deletions or exon 21 L858R substitution mutations.
Read More
